CD2/CD19, FITC, PE, clone: T6.3, 1G9, Invitrogen
Manufacturer: Invitrogen MA112056
CD2 is found on the majority of human T and NK cells. CD2 presents on 78+8% normal peripheral lymphocytes and 100% of thymocytes. This antibody detects CD2 antigen CD19 is a member of the immunoglobulin superfamily and has two Ig like domains. The CD19 molecule is expressed on 100% of the peripheral B cells as defined by expression of kappa or lamda light chains. It appears to be expressed on myeloid leukemia cells, particularly those of monocytic lineage. Leukemia phenotype studies have demonstrated that the earliest and broadest B cell restricted antigen is the CD19 antigen. The receptor for CD19 is an important functional regulator of normal and malignant B cell proliferation. It is expressed in all B cell precursor leukemias.This antibody is a monoclonal mixture of FITC-conjugated CD2 (clone T6.3, isotype IgG2a) and PE-conjugated CD19 (clone 1G9, isotype IgG1).
|CD2 + CD19|
|T lymphocytes activated by mixed lymphocyte culture|
|Protein A/G, Protein A/G|
|PBS with 0.2% carrier protein and 0.08% sodium azide|
|LFA-2, 2CD2 antigen, sheep red blood cell receptor, LFA-3 receptor, T-cell surface antigen CD2, T-cell surface antigen T11/Leu-5, erythrocyte receptor, lymphocyte-function antigen-2, rosette receptor, AW495831, B-lymphocyte antigen CD19, differentiation antigen CD19|
|Store at 4°C|
|914, 914, 930, 930|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok